GlaxoSmithKline Pharmaceuticals Limited (GLAXO) AI stock analysis

FutureGain's AI scores GlaxoSmithKline Pharmaceuticals Limited (GLAXO) in Healthcare 65/100, a bullish reading on its 3–12 months horizon, as of 2026-11-11. The score combines technical trend, momentum, volume, breakout, fundamentals, F&O positioning, delivery and sentiment. It is research, not investment advice.

AI score 65/100 · BULLISH · Healthcare